Physician profile
Robert M Grossmann
NPI 1306917554
$4,634.10
in general payments reported to CMS, 2019-2025
15 companies · $527 in 2025
The $527 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $120 · 2021: $193 · 2022: $375 · 2023: $2,526 · 2024: $686 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,893 · Food and Beverage: $1,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,892.64 |
| Food and Beverage | $1,845.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,289.52 | 2023 | Visumax |
| Alcon Vision LLC | $722.73 | 2020-2025 | Clareon, Clareon Panoptix Pro, Simbrinza |
| Johnson & Johnson Surgical Vision, INC. | $305.33 | 2020-2025 | |
| Oyster Point Pharma, INC. | $228.80 | 2022-2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $216.81 | 2019-2021 | |
| Dompe US, INC. | $200.00 | 2023-2025 | Oxervate |
| Glaukos Corporation | $125.65 | 2022 | |
| Bausch & Lomb Americas INC. | $124.31 | 2024 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $120.84 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.06 | 2019 | |
| Abbvie INC. | $69.07 | 2024 | |
| Allergan, INC. | $67.78 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $31.83 | 2023 | Acuvue |
| Rxsight INC | $16.25 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grossmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.